IGFBP3 and Alzheimer disease: Our CSF proteomic analysis and bioinformatics findings, coupled with functional validation, support the hypothesis that decreased IGFBP3 is involved in PDD pathogenesis, potentially sharing mechanisms with AD and age-related cognitive decline.